Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Been a while since I bought and it hasn't closed below my purchase price.
My condolences if you held through Sunrise failure. At this point not too much more downside exposure. Perhaps another 10-20% with the RS coming in 10 days or so.
Of course the vote will pass. Of course they will rs. Who would partner a failed drug?
Yet those opinions have been 100% wrong so far. BAVI has failed all late trials. Based on volume and price a near certainty Monday is a non-event.
Likely 9 more days to RS effective date.
Doing what they do to pphm? What different treatment do you think pphm receives?
MM shorting is shown as ShortVolumeExempt on the FINRA Report
I disagree and one should THINK two hundred times about their future and if one is lucky enough to have PPHM shares then hold them and hold them and yes....HOLD those PPHM shares
http://regsho.finra.org/DailyShortSaleVolumeFileLayout.pdf
The key word is Aggregated for short volume. The exempt (mm trades) are in there too.
Sorry but you are misinterpreting this. If an Investor is long 500 shares and desires to sell. They enter the order through their broker that is routed to a market maker. The market maker will sell the stock into the market before they have bought the stock from your broker to close their account. They did not take possession first as there is no guarantee they can sell the order into the market. The actual sale INTO the market is a naked short sale, the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality, the position will be closed out seconds, minutes when they actually buy your shares.
I see you believe 62% short PLUS the MM short positions - that makes sense.
You don't understand how mm use intraday shorting.
scare tactics, manipulation, false info, doom and gloom
No Proof? mgmt. annoounced a RS. You think they announce they failed, can't stay listed and then don't do the RS?
THE RS will likely happen th onday after vote. The ESCO news will almost certainly be a minor to non-event. It is just a few days away and no shareprice increase and low volume. As others have commented it takes volume to move price in your direction - unless there is no buying interest.
Kind of the same technique was used on the Sunrise STOP news to 'exponentially' make our PPHM PPS overreact in the down direction.
ESMO will be a non-event. If there was big big news coming as some believe, it would be reflected in the share price, pretty basic stuff. ESMO sells off after a little bump and RS is Monday after vote.
To be honest. There are multiple proofs that Bavi works.
I appreciate a real dialogue but obvious stretching and straight up lying doesn't float.
PPHM never said they were disappointed with results...recheck your facts.
It is a broken penny stocked that gained a few pennies after ablack swan event. There is hardly a bullish consensus on pphm.
PPHM said so -
They are presenting their findings at ESMO
Esmo is allowing them to present their material.
NCCN has partnered PPHM's Bavi with other companies to test the possibility of success with specific other products.
Glad you put the LOL! I would expect the RS on Monday after the vote.
The RS will likely be effective the following Monday. 7:1
Super news? What super news. Bungler was comparing apples and oranges. You can't use a metric based on sales of products in drug pipeline with a company whse sales are low margin mfg.
Trials plural? Now multiple trials were sabotaged to keep bavi out of the market. Why bother it fails on its own.
There is 0 proof the botched PII involved any bp. Where are the indictments? Why has pphm NEVER suggested this?
Prediction: 17 October RS is effective, at the 7:1 ratio.
Since clearly the entire data-set was not statsig (the trial was stopped for efficacy) The only possibility is that it is a subset. It does not need to be explicitly stated because it is obvious.
I have no doubt PPHM will explore this. That will be after RS #9 and all cancer trials have continued to fail.
Possibly, the issue is that large chunk owned by somebody (family) that won't let the pps move to it fair market position. Back in 2012 at least 200M shares transacted in two days yet no 5% filings. Again 30M in one day and no filings.
Maybe the plan is to dilute them (hopefully bringing in friendly partner) by selling majority or large sum to new party at a fair market price.
So if you vote NO you can still participate in the trials and class actions that fight the fact that PPHM changed the voting power indirectly by a Reverse Split, mentioning that they would not split the Authorized, but WITHOUT submitting it to a vote as required for voting power changing matters.
Yes sales of what? Sales of products from new drug development, or sales of manufacturing services that anyone can replicate?
You are comparing apples and oranges. Your metrics are for biotechs with revenue from products not biotechs with low margin generic manufacturing revenues.
Of course there will be. Within a few weeks at most (mor elikely days) of the vote.
BPs naturally don't want cures and PS Targeting has shown signs of this
The ultimate result of a RS may depend, at times, whether the resulting share price elicits a TO from another company shortly after the effective date of the RS.
o, IF ESMO Presentation Confirms Phase2 Results Validity...
On a side note, if they were to show a profit on this q and the expectations are the same going forward there is < 1%
Chevy, it seems obvious to me that that one cent uptick after 8 million traded is accumulation.